(Q38399502)

2 September 2017

title

Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma (English)

1 reference

2 September 2017

6

Kari Syrjänen

1 reference

2 September 2017

Adam Elzagheid

1

1 reference

2 September 2017

Fatma Emaetig

2

1 reference

2 September 2017

Abdelbaset Buhmeida

3

1 reference

2 September 2017

Matti Laato

4

1 reference

2 September 2017

Omran El-Faitori

5

1 reference

2 September 2017

Yrjö Collan

7

1 reference

2 September 2017

Seppo Pyrhönen

8

1 reference

2 September 2017

publication date

21 November 2012

1 reference

2 September 2017

1 reference

2 September 2017

volume

34

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

621-628

1 reference

2 September 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Colon cancer and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Molecular prognostic markers and colorectal cancer: the search goes on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

21 January 2018

Epithelial mucin genes

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Mucin gene expression in the human endocervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Short rare MUC6 minisatellites-5 alleles influence susceptibility to gastric carcinoma by regulating gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Adjuvant chemotherapy in colon cancer: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Significance of MUC1 and MUC2 mucin expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Transcriptional activation of the MUC2 gene by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Expression of mucin antigens in human cancers and its relationship with malignancy potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Response to chemotherapy (irinotecan plus 5-fluorouracil) in colorectal carcinoma can be predicted by tumour DNA content

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Are there two sides to colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

One colon lumen but two organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0588-8

Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer

21 January 2018

1 reference

12 December 2020

Loss of MUC2 expression correlates with progression along the adenoma-carcinoma sequence pathway as well as de novo carcinogenesis in the colon.

1 reference

12 December 2020

Predictors of distant metastasis and mortality in patients with stage II colorectal cancer

1 reference

12 December 2020

Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours

1 reference

12 December 2020

DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.

1 reference

12 December 2020

Genetic prognostic markers for colorectal cancer

1 reference

12 December 2020

Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core

1 reference

12 December 2020

MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients

1 reference

12 December 2020

Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression

1 reference

12 December 2020

Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7)

1 reference

12 December 2020

Prognostic significance of MUC1 epithelial mucin expression in breast cancer

1 reference

12 December 2020

Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.

1 reference

12 December 2020

MUC2 gene promoter methylation in mucinous and non-mucinous colorectal cancer tissues.

1 reference

12 December 2020

MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation

1 reference

12 December 2020

Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism

1 reference

12 December 2020

Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer

1 reference

12 December 2020

Expression of MUC1 and MUC2 mucins and relationship with cell proliferative activity in human colorectal neoplasia

1 reference

12 December 2020

10.1007/S13277-012-0588-8

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1040467071

0 references

1 reference